In Vivo Reversal of the Anticoagulant Effect of Rivaroxaban with 4-Factor Prothrombin Complex Concentrate
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2014
Price : $35 *
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Pharmacodynamics
- 29 Apr 2014 New trial record
- 29 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 29 Mar 2014 Primary endpoint 'Antithrombin-activity' has been met.